Literature DB >> 2162318

Ovarian epithelial tumors of borderline malignancy in Japan.

N Nakashima1, T Nagasaka, N Oiwa, Y Nara, S Fukata, T Fukatsu, J Takeuchi.   

Abstract

Seventy-one cases of ovarian epithelial tumor of borderline malignancy have been surveyed from a clinicopathologic viewpoint. The majority of the borderline tumors (73.2%) were of the mucinous type, versus only 16.9% of the serous type. The other types--endometrioid (2.8%), Brenner (1.4%), and mixed type (5.6%)--were much rarer. Patients with mucinous tumors were significantly younger (mean age 42.6) than those with serous tumors (mean age 57.5) (P less than 0.01). Of patients with mucinous tumors, 64.2% were of reproductive age (15-45 years), compared with 17% of patients with serous tumors. Some 78.8% of mucinous and 83.3% of serous borderline tumors were FIGO stage I. Serous tumors were more frequently bilateral (66.7%) than mucinous tumors (9.8%). In mucinous borderline tumors, the extent of tumor spread at the first laparotomy had an intimate relationship to the prognosis, but in serous borderline tumors, it was insignificant. The survival rate of patients with mucinous borderline tumors was 69.3% at 5 years and 62.4% at 10 years (Kaplan-Meier method). Most patients with pseudomyxoma peritonei classified as borderline at the time of discovery died within 5 years of the operation. The prognosis of the serous type was extremely favorable. Criteria for borderline tumors of various cell types and differences in the clinicopathologic data of ovarian borderline tumors between Japan and other countries were discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2162318     DOI: 10.1016/0090-8258(90)90017-f

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

Review 1.  Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects.

Authors:  Jian-Jun Wei; Josette William; Serdar Bulun
Journal:  Int J Gynecol Pathol       Date:  2011-11       Impact factor: 2.762

Review 2.  Interventions for the treatment of borderline ovarian tumours.

Authors:  Olusola Faluyi; Melanie Mackean; Charlie Gourley; Andrew Bryant; Heather O Dickinson
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

3.  Ovarian mucinous borderline tumor with anaplastic carcinomatous nodules in adolescents.

Authors:  Mengqi Huang; Qian Lv; Jingyan Xie
Journal:  J Ovarian Res       Date:  2022-07-14       Impact factor: 5.506

4.  Borderline ovarian tumours in Vaud, Switzerland: incidence, survival and second neoplasms.

Authors:  F Levi; C La Vecchia; L Randimbison; V C Te
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

5.  Clinicopathological aspects of patients with recurrence of borderline ovarian tumors.

Authors:  Sumin Oh; Ran Kim; Yoo-Kyung Lee; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song
Journal:  Obstet Gynecol Sci       Date:  2015-03-16

6.  Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy.

Authors:  Toshiyuki Okumura; Etuo Muronosono; Masahiko Tsubuku; Yasuhisa Terao; Satoru Takeda; Masanori Maruyama
Journal:  J Ovarian Res       Date:  2018-09-03       Impact factor: 4.234

7.  Allelic loss at 19q12 and Xq11-12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential.

Authors:  K Nakayama; Y Takebayashi; K Hata; R Fujiwaki; K Iida; M Fukumoto; K Miyazaki
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.